Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of GBP 42.01 billion. The enterprise value is 49.55 billion.
| Market Cap | 42.01B |
| Enterprise Value | 49.55B |
Important Dates
The next confirmed earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Apr 27, 2026 |
Share Statistics
| Current Share Class | 129.24M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 15.25% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 18.46 and the forward PE ratio is 14.37.
| PE Ratio | 18.46 |
| Forward PE | 14.37 |
| PS Ratio | 2.28 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 16.06 |
| P/FCF Ratio | 20.52 |
| P/OCF Ratio | 12.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.03, with an EV/FCF ratio of 24.20.
| EV / Earnings | 21.78 |
| EV / Sales | 2.71 |
| EV / EBITDA | 10.03 |
| EV / EBIT | 14.54 |
| EV / FCF | 24.20 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.46 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 5.10 |
| Interest Coverage | 12.06 |
Financial Efficiency
Return on equity (ROE) is 8.92% and return on invested capital (ROIC) is 8.23%.
| Return on Equity (ROE) | 8.92% |
| Return on Assets (ROA) | 4.76% |
| Return on Invested Capital (ROIC) | 8.23% |
| Return on Capital Employed (ROCE) | 9.25% |
| Weighted Average Cost of Capital (WACC) | 7.34% |
| Revenue Per Employee | 311,607 |
| Profits Per Employee | 38,512 |
| Employee Count | 59,077 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, Merck KGaA has paid 604.55 million in taxes.
| Income Tax | 604.55M |
| Effective Tax Rate | 20.95% |
Stock Price Statistics
The stock price has decreased by -9.57% in the last 52 weeks. The beta is 0.80, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -9.57% |
| 50-Day Moving Average | 114.87 |
| 200-Day Moving Average | 115.41 |
| Relative Strength Index (RSI) | 42.74 |
| Average Volume (20 Days) | 114,406 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of GBP 18.41 billion and earned 2.28 billion in profits. Earnings per share was 5.23.
| Revenue | 18.41B |
| Gross Profit | 10.84B |
| Operating Income | 3.43B |
| Pretax Income | 2.89B |
| Net Income | 2.28B |
| EBITDA | 4.97B |
| EBIT | 3.43B |
| Earnings Per Share (EPS) | 5.23 |
Balance Sheet
The company has 2.91 billion in cash and 10.44 billion in debt, giving a net cash position of -7.53 billion.
| Cash & Cash Equivalents | 2.91B |
| Total Debt | 10.44B |
| Net Cash | -7.53B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.00B |
| Book Value Per Share | 57.37 |
| Working Capital | 3.65B |
Cash Flow
In the last 12 months, operating cash flow was 3.43 billion and capital expenditures -1.38 billion, giving a free cash flow of 2.05 billion.
| Operating Cash Flow | 3.43B |
| Capital Expenditures | -1.38B |
| Depreciation & Amortization | 1.53B |
| Net Borrowing | 1.45B |
| Free Cash Flow | 2.05B |
| FCF Per Share | n/a |
Margins
Gross margin is 58.90%, with operating and profit margins of 18.62% and 12.36%.
| Gross Margin | 58.90% |
| Operating Margin | 18.62% |
| Pretax Margin | 15.68% |
| Profit Margin | 12.36% |
| EBITDA Margin | 27.01% |
| EBIT Margin | 18.62% |
| FCF Margin | 11.12% |
Dividends & Yields
This stock pays an annual dividend of 1.91, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | 1.91 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | 2.03% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.84% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.74% |
| Earnings Yield | 5.42% |
| FCF Yield | 4.87% |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 5 |